Literature DB >> 26088359

Challenges in childhood tuberculosis.

S Swaminathan1, G Ramachandran1.   

Abstract

While tuberculosis (TB) typically causes respiratory disease in adults, the spectrum of disease is different in children, ranging from paucibacillary lymphadenitis or limited intrathoracic disease to severe disseminated disease. Diagnosing pediatric TB and monitoring treatment response is challenging, as collecting respiratory specimens is difficult in children and disease may be extrapulmonary. While basic principles of treatment are similar to adults, developmental differences in pharmacokinetics and pharmacodynamics require that drug dosages in children be adjusted for body weight and age.
© 2015 ASCPT.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26088359     DOI: 10.1002/cpt.175

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  9 in total

1.  Multiparameter Responses to Tedizolid Monotherapy and Moxifloxacin Combination Therapy Models of Children With Intracellular Tuberculosis.

Authors:  Devyani Deshpande; Shashikant Srivastava; Eric Nuermberger; Thearith Koeuth; Katherine R Martin; Kayle N Cirrincione; Pooi S Lee; Tawanda Gumbo
Journal:  Clin Infect Dis       Date:  2018-11-28       Impact factor: 9.079

2.  Evidence to Action: Translating Innovations in Management of Child and Adolescent TB into Routine Practice in High-Burden Countries.

Authors:  Brittany K Moore; Riitta A Dlodlo; John Paul Dongo; Sabine Verkuijl; Moorine P Sekadde; Charles Sandy; Susan A Maloney
Journal:  Pathogens       Date:  2022-03-23

3.  Childhood Tuberculosis in a Sub-Saharan Tertiary Facility: Epidemiology and Factors Associated with Treatment Outcome.

Authors:  Loukia Aketi; Zacharie Kashongwe; Christian Kinsiona; Serge Bisuta Fueza; Jack Kokolomami; Grace Bolie; Paul Lumbala; Joseph Shiku Diayisu
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

4.  Drug Concentration Thresholds Predictive of Therapy Failure and Death in Children With Tuberculosis: Bread Crumb Trails in Random Forests.

Authors:  Soumya Swaminathan; Jotam G Pasipanodya; Geetha Ramachandran; A K Hemanth Kumar; Shashikant Srivastava; Devyani Deshpande; Eric Nuermberger; Tawanda Gumbo
Journal:  Clin Infect Dis       Date:  2016-11-01       Impact factor: 9.079

5.  Examining the quality of childhood tuberculosis diagnosis in Cambodia: a cross-sectional study.

Authors:  Julia B Frieze; Rajendra-Prasad Yadav; Khann Sokhan; Song Ngak; Team Bak Khim
Journal:  BMC Public Health       Date:  2017-03-06       Impact factor: 3.295

6.  Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa.

Authors:  André G Loxton; Julia K Knaul; Leander Grode; Andrea Gutschmidt; Christiane Meller; Bernd Eisele; Hilary Johnstone; Gian van der Spuy; Jeroen Maertzdorf; Stefan H E Kaufmann; Anneke C Hesseling; Gerhard Walzl; Mark F Cotton
Journal:  Clin Vaccine Immunol       Date:  2017-02-06

7.  Repurposing Cefazolin-Avibactam for the Treatment of Drug Resistant Mycobacterium tuberculosis.

Authors:  Shashikant Srivastava; Tawanda Gumbo; Tania Thomas
Journal:  Front Pharmacol       Date:  2021-10-22       Impact factor: 5.810

Review 8.  Partnerships to Design Novel Regimens to Treat Childhood Tuberculosis, Sui Generis: The Road Ahead.

Authors:  Tawanda Gumbo; Mamodikoe K Makhene; James A Seddon
Journal:  Clin Infect Dis       Date:  2016-11-01       Impact factor: 9.079

9.  Suboptimal Antituberculosis Drug Concentrations and Outcomes in Small and HIV-Coinfected Children in India: Recommendations for Dose Modifications.

Authors:  Benjamin Guiastrennec; Geetha Ramachandran; Mats O Karlsson; A K Hemanth Kumar; Perumal Kannabiran Bhavani; N Poorana Gangadevi; Soumya Swaminathan; Amita Gupta; Kelly E Dooley; Radojka M Savic
Journal:  Clin Pharmacol Ther       Date:  2018-02-02       Impact factor: 6.875

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.